APLS vs HLT · rev $1.00B vs P/E 51, rev $6.28B
Apellis Pharmaceuticals Inc (APLS) versus Hilton Worldwide Holdings Inc (HLT) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Hilton Worldwide Holdings Inc (HLT) is a lodging company listed on US.
Latest reported APLS revenue for 2025-12-31 was $1.00B. Net income was $22.4M. Revenue was up 28.5% from 2024-12-31 to 2025-12-31. APLS currently screens at market cap $2.29B.
Latest reported HLT revenue for 2026-06-30 was $6.28B. Net income was $867.0M. HLT currently screens at market cap $75.44B and trailing P/E 50.5.
APLS currently screens at market cap $2.29B. HLT currently screens at market cap $75.44B and trailing P/E 50.5.
Not investment advice. Open the APLS and HLT stock pages for the full models.
Not investment advice.